Anavex生命科學AVXL
那斯達克 · USD
11.20
-0.10
(-0.88%)
收盤 08/02 03:59 (UTC+8)
盤後
11.15
11.15
(-0.45%)
08/02 03:59 (UTC+8)
Anavex生命科學AVXL
11.20
-0.10
(-0.88%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | - | - | 14,336 | - | - | 11,293 | 12,652 | 13,530 | 14,190 | 15,384 |
研發費用 | 9,892 | 10,446 | 11,555 | 11,870 | 9,729 | 8,684 | 10,060 | 10,283 | 11,307 | 12,067 |
推銷及管理費用 | 2,621 | 3,146 | 2,781 | 2,668 | 2,705 | 2,609 | 2,592 | 3,247 | 2,883 | 3,317 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -12,513 | -13,592 | -14,336 | -14,538 | -12,434 | -11,293 | -12,652 | -13,531 | -14,189 | -15,384 |
其他收入及費用 | 1,317 | 1,481 | 2,592 | 2,448 | 2,079 | 2,756 | 2,442 | 2,292 | 1,132 | 2,392 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -11,196 | -12,111 | -11,744 | -12,090 | -10,355 | -8,537 | -10,210 | -11,239 | -13,057 | -12,992 |
所得稅 | - | - | -124 | 124 | 191 | 85 | -64 | 41 | 50 | -20 |
稅後純益 | -11,196 | -12,111 | -11,620 | -12,214 | -10,546 | -8,622 | -10,146 | -11,280 | -13,107 | -12,972 |
基本每股稅後盈餘(元) | -0.13 | -0.14 | -0.14 | -0.14 | -0.13 | -0.11 | - | -0.14 | -0.17 | -0.17 |
稀釋每股稅後盈餘(元) | -0.13 | -0.14 | -0.14 | -0.15 | -0.12 | -0.11 | -0.13 | -0.14 | -0.16 | -0.17 |
基本平均股數(千股) | 85073.00 | 84805.00 | 84796.00 | 84535.00 | 82464.00 | 82077.00 | - | 80875.00 | 78304.00 | 77977.00 |
稀釋平均股數(千股) | 85073.00 | 84805.00 | 84796.00 | 84535.00 | 82464.00 | 82077.00 | - | 80875.00 | 78304.00 | 77977.00 |
還原基本每股稅後盈餘(元) | -0.13 | -0.14 | -0.14 | -0.14 | -0.13 | -0.11 | - | -0.14 | -0.17 | -0.17 |
還原稀釋每股稅後盈餘(元) | -0.13 | -0.14 | -0.14 | -0.15 | -0.12 | -0.11 | -0.13 | -0.14 | -0.16 | -0.17 |
還原基本平均股數(千股) | 85,073 | 84,805 | 84,796 | 84,535 | 82,464 | 82,077 | - | 80,875 | 78,304 | 77,977 |
還原稀釋平均股數(千股) | 85,073 | 84,805 | 84,796 | 84,535 | 82,464 | 82,077 | - | 80,875 | 78,304 | 77,977 |
EBITDA(千元) | -11,196 | -12,111 | -11,744 | -12,090 | -10,355 | -8,537 | -10,210 | -11,239 | -13,057 | -12,992 |